EX-23.2 4 s-8exhibit232consentk.htm EX-23.2 Document

EXHIBIT 23.2
kp1.jpg
KPMG LLP
345 Park Avenue
New York, NY 10154-0102
Consent of Independent Registered Public Accounting Firm


We consent to the use of our reports dated February 22, 2024, with respect to the consolidated financial statements of Pfizer Inc. and Subsidiary Companies, and the effectiveness of internal control over financial reporting, incorporated herein by reference.
/s/ KPMG LLP


New York, New York
February 23, 2024